1. AHRO : Austin Health Research Online

Peter P De Cruz

View Statistics Email Alert

Profile

Loading... 2 0 5 0 false
Credit Name
Peter P De Cruz
Full Name
De Cruz, Peter P
 
Variants
De Cruz, Peter
 
Department
 
ORCID
Loading... 3 0 5 0 false

Publications

Results 1-20 of 28 (Search time: 0.013 seconds).

Publication YearTitleAuthor(s)
111-Mar-2021A Single Educational Intervention Improves Pregnancy-Related Knowledge and Emotional Health Among Women With IBD Who Are Pregnant or Wish to Conceive.Flanagan, Emma; Wright, Emily K; Sparrow, Miles P; Moore, Gregory T; Connell, William R; De Cruz, Peter P ; Christensen, Britt; Shelton, Edward; Kamm, Michael A; Ward, Mark G; Dowling, Damian; Brown, Steven; Kashkooli, Soleiman; Thompson, Alexander J; Ross, Alyson L; Kiburg, Katerina V; Bell, Sally J
225-Feb-2021Development and Feasibility of a Web-Based Decision Aid for Patients With Ulcerative Colitis: Qualitative Pilot Study.Kim, Andrew H; Girgis, Afaf; De Cruz, Peter P ; Siegel, Corey A; Karimi, Neda; Ruban, Sasha O; Sechi, Alexandra J; Ng, Wa Sang Watson; Andrews, Jane M; Connor, Susan J
311-Feb-2021Impact of inflammatory bowel disease and azathioprine on long-term outcomes after liver transplantation for primary sclerosing cholangitis.Peverelle, Matthew R ; De Cruz, Peter P ; Paleri, Sarang; Gow, Paul J 
411-Feb-2021Real-World Effectiveness of Ustekinumab Dose Intensification in Crohn's Disease.Srinivasan, Ashish ; van Langenberg, Daniel; De Cruz, Peter P 
51-Nov-2020Luminal microbiota related to Crohn's disease recurrence after surgery.Hamilton, Amy L; Kamm, Michael A; De Cruz, Peter P ; Wright, Emily K; Feng, Hai; Wagner, Josef; Sung, Joseph J Y; Kirkwood, Carl D; Inouye, Michael; Teo, Shu-Mei
6Sep-2020Immune therapies in ulcerative colitis: are we beyond anti-TNF yet?Raine, Tim; Verstockt, Bram; De Cruz, Peter P 
716-Aug-2020Tofacitinib is Safe and Effective When Used in Combination With Infliximab for the Management of Refractory Ulcerative Colitis.Gilmore, Robert B ; Hilley, Patrick; Srinivasan, Ashish ; Choy, Matthew C ; Grace, Josephine A ; De Cruz, Peter P 
814-Aug-2020Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford.Pulusu, Samba Siva Reddy; Srinivasan, Ashish ; Krishnaprasad, Krupa; Cheng, Daniel; Begun, Jakob; Keung, Charlotte; Van Langenberg, Daniel; Thin, Lena; Mogilevski, Tamara; De Cruz, Peter P ; Radford-Smith, Graham; Flanagan, Emma; Bell, Sally; Kashkooli, Soleiman; Sparrow, Miles; Ghaly, Simon; Bampton, Peter; Sawyer, Elise; Connor, Susan; Rizvi, Quart-Ul-Ain; Andrews, Jane M; Mahy, Gillian; Chivers, Paola; Travis, Simon; Lawrance, Ian Craig
9Aug-2020Letter: choosing between ustekinumab and vedolizumab in anti-TNF refractory Crohn's disease-the devil is in the detail.Srinivasan, Ashish ; De Cruz, Peter P ; van Langenberg, Daniel R
10Aug-2020Letter: ustekinumab dose intensification for loss of response-should we re-induce before shortening the dose interval?Srinivasan, Ashish ; De Cruz, Peter P ; van Langenberg, Daniel R
1117-Jul-2020Anti-TNF-associated immunogenicity: use a retroactive drug but a proactive approach.Srinivasan, Ashish ; De Cruz, Peter P ; van Langenberg, Daniel R
12Jun-2020A virtual clinic increases anti-TNF dose intensification success via a treat-to-target approach compared with standard outpatient care in Crohn's disease.Srinivasan, Ashish ; van Langenberg, Daniel R; Little, Robert D; Sparrow, Miles P; De Cruz, Peter P ; Ward, Mark G
13Jun-2020Letter: how can we reduce mortality in elderly patients with acute severe ulcerative colitis?Li Wai Suen, Christopher F D; Choy, Matthew C ; De Cruz, Peter P 
1411-Apr-2020Letter Re: Safety of Combination Biologic and Antirejection Therapy Post-liver Transplantation in Patients With Inflammatory Bowel DiseasePeverelle, Matthew R ; Mills, Chris; Testro, Adam G ; Gow, Paul J ; De Cruz, Peter P 
1511-Apr-2020Letter to the Editor: Antibiotic Cocktail for Pediatric Acute Severe Colitis and the Microbiome: The PRASCO Randomized Controlled Trial.Gilmore, Robert B ; Choy, Matthew C ; Li Wai Suen, Christopher F D; De Cruz, Peter P 
1631-Mar-2020Ustekinumab is a safe and effective biologic agent for Crohn's disease in a Liver Transplant patient.Peverelle, Matthew R ; Asadi, Khashayar ; De Cruz, Peter P 
17Mar-2020Letter: infliximab induction regimens in steroid-refractory acute severe colitis-a propensity score analysis.Li Wai Suen, Christopher F D; Choy, Matthew C ; De Cruz, Peter P 
1820-Feb-2020Letter Re: Safety of Combination Biologic and Antirejection Therapy Post-liver Transplantation in Patients With Inflammatory Bowel Disease.Peverelle, Matthew R ; Mills, Christopher D; Testro, Adam G ; Gow, Paul J ; De Cruz, Peter P 
1916-Jan-2020Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes.Peverelle, Matthew R ; Paleri, Sarang; Hughes, Jed ; De Cruz, Peter P ; Gow, Paul J 
202020Using Ustekinumab to Treat Crohn's Disease-Related Orofacial Granulomatosis: Two Birds, One Stone.Gilmore, Robert B ; Li Wai Suen, Christopher F D; Elliott, Tim; De Cruz, Peter P ; Srinivasan, Ashish